Abstract

Review Article

Packaging challenge for COVID-19 drug

Anupam Chand*

Published: 09 November, 2019 | Volume 4 - Issue 1 | Pages: 028-036

At present Corona virus is the most burning topic across the world. At present there is no drug available to cure 100%. So many companies are trying to make it possible as soon as they can. The basic characteristics of the product is “Non-Toxic made of sugars Carbohydrates”. A Galectin is a protein that recognizes carbohydrates and modulates intracellular and extracellular interactions primarily related to the immune system. In some cases Galectins act as a glue bringing molecules together. The major focus of the research is on extracellular interactions.

Read Full Article HTML DOI: 10.29328/journal.abb.1001019 Cite this Article Read Full Article PDF

References

  1. pda.org
  2. glass-ts.com
  3. sciencedirect.com
  4. Highlights from June 2011 Glass Container Delamination Scientific Symposium. 2013. http://www.rx-360.org/LinkClick.aspx?
  5. Swift, Rob Amgen presentations, PDA April 2011 San Antonio; PDA/FDA Glass Quality Conference May 2011.
  6. http://www.fda.gov/Drugs/DrugSafety/ucm248490.htm
  7. Ennis RD, Pritchard R, Nakamura C, Coulon M, Yang T, et al. Glass vials for small volume parenterals: influence of drug and manufacturing processes on glass delamination. Pharm Dev Tech. 2001; 6: 393-405. https://pubmed.ncbi.nlm.nih.gov/11485181/
  8. Desmond H. USP Presentation, PDA/FDA Glass Quality Conference May 2013.
  9. https://www.sciencedaily.com/releases/2020/09/200915152448.htm
  10. https://youtu.be/FD0fhZB3bUE
  11. https://investor.regeneron.com/static-files/a596a85e-e72d-4529-8eb5-d52d87a99070
  12. https://www.businessinsider.com/regeneron-ceo-says-trump-antibody-drug-experience-weakest-evidence-success-2020-10
  13. https://www.cbsnews.com/news/transcript-regeneron-ceo-leonard-schleifer-on-face-the-nation-october-11-2020/

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Figure 1

Figure 3

Figure 1

Figure 4

Figure 1

Figure 5

Figure 1

Figure 6

Figure 1

Figure 7

Figure 1

Figure 8

Figure 1

Figure 9

Similar Articles

Recently Viewed

  • What is the Cost of Measuring a Blood Pressure?
    Steven A Yarows* Steven A Yarows*. What is the Cost of Measuring a Blood Pressure?. Ann Clin Hypertens. 2018: doi: 10.29328/journal.ach.1001012; 2: 059-066
  • Coexistence of common gallstones and sinusoidal obstruction syndrome: Case report and review of the literature
    Furkan Karahan*, Nihan Acar, Arzu Avcı and Osman Nuri Dilek Furkan Karahan*,Nihan Acar,Arzu Avcı,Osman Nuri Dilek. Coexistence of common gallstones and sinusoidal obstruction syndrome: Case report and review of the literature. Arch Surg Clin Res. 2021: doi: 10.29328/journal.ascr.1001060; 5: 020-022
  • The Immunitary role in chronic prostatitis and growth factors as promoter of BPH
    Mauro luisetto*, Behzad Nili-Ahmadabadi, Ghulam Rasool Mashori, Ram Kumar Sahu, Farhan Ahmad Khan, Cabianca luca and Heba Nasser Mauro luisetto*,Behzad Nili-Ahmadabadi,Ghulam Rasool Mashori,Ram Kumar Sahu,Farhan Ahmad Khan,Cabianca luca,Heba Nasser. The Immunitary role in chronic prostatitis and growth factors as promoter of BPH. Insights Clin Cell Immunol. 2018: doi: 10.29328/journal.icci.1001003; 2: 001-013
  • Huge median prostatic lobe: a interesting case of BPH
    Babty Mouftah*, Slaoui Amine, Fouimtizi Jaafar, Mamad Ayoub, Karmouni Tarik, El Khadder Khalid, Koutani Abdellatif and Ibn Attya Ahmed Babty Mouftah*,Slaoui Amine,Fouimtizi Jaafar,Mamad Ayoub,Karmouni Tarik,El Khadder Khalid,Koutani Abdellatif,Ibn Attya Ahmed. Huge median prostatic lobe: a interesting case of BPH. J Clin Med Exp Images. 2022: doi: 10.29328/journal.jcmei.1001026; 6: 006-006
  • Prostate health in India (BPH & Prostate Cancer)
    Suresh Kishanrao* Suresh Kishanrao*. Prostate health in India (BPH & Prostate Cancer). Arch Cancer Sci Ther. 2022: doi: 10.29328/journal.acst.1001028; 6: 009-017

Read More

Most Viewed

Read More

Help ?